Cerevel Therapeutics: A Whimsical Tale of a $300 Million Private Offering and a $254 Million Public Offering
Cerevel Therapeutics Announces Pricing of $300 Million Private Offering of Convertible Senior Notes What is Cerevel Therapeutics? Cerevel Therapeutics Holdings, Inc. is a company based in Cambridge, Massachusetts that is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. Their mission is to develop innovative treatments for conditions that affect the brain…